ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,644.81
      1.30%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      03/06/20184:05PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/28/20188:00AMGlobeNewswire Inc.Aclaris Therapeutics to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results on March 12, 2...NASDAQ:ACRSAclaris Therapeutics Inc
      02/14/20182:53PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/14/20182:03PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/14/20188:23AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/13/20189:35AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/08/20185:44PMGlobeNewswire Inc.Aclaris Therapeutics to Present Data on ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) at the 2018 American Academ...NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/02/20188:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      02/01/20189:35AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      01/30/20184:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      01/08/20187:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      01/08/20187:00AMGlobeNewswire Inc.Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Endpoints in Two Phase 2 Clinical Trials f...NASDAQ:ACRSAclaris Therapeutics Inc
      01/04/20184:01PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20174:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20174:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20174:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20174:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/20174:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20177:00AMGlobeNewswire Inc.Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with VitiligoNASDAQ:ACRSAclaris Therapeutics Inc
      12/15/201711:12AMDow Jones NewsGOP Tax Plan: Child Tax-Credit Gets Increase, But Is It Enough to Satisfy Rubio?NASDAQ:ACRSAclaris Therapeutics Inc
      12/15/201711:08AMDow Jones NewsGOP Tax Plan: Lawmakers Start to Sign Still-Secret Tax BillNASDAQ:ACRSAclaris Therapeutics Inc
      12/15/20177:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      12/15/20177:00AMGlobeNewswire Inc.Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment o...NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS

      Your Recent History

      BIT
      UB30FE
      UniCredit Bank
      Delayed Upgrade Clock